These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2492738)

  • 21. Clinical and electrophysiologic characteristics in patients with Wolff-Parkinson-White pattern.
    Antunes E; da Silva N; Catarino C; Serra J; Galrinho A; Ferreira R; Quininha J; Gracias R; Rato JA
    Rev Port Cardiol; 1993 Apr; 12(4):333-6. PubMed ID: 8512728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiologic effects of isoproterenol in patients with atrioventricular reentrant tachycardia treated with flecainide.
    Helmy I; Scheinman MM; Herre JM; Sharkey H; Griffin JC
    J Am Coll Cardiol; 1990 Dec; 16(7):1649-55. PubMed ID: 2123908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter long-term results of antitachycardia pacing for supraventricular tachycardias.
    Kappenberger L; Valin H; Sowton E
    Am J Cardiol; 1989 Jul; 64(3):191-3. PubMed ID: 2662744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia.
    Musto B; D'Onofrio A; Cavallaro C; Musto A; Greco R
    Am J Cardiol; 1988 Aug; 62(4):229-33. PubMed ID: 3135739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of flecainide in pacing-induced sustained ventricular tachyarrhythmias: correlation to clinical parameters and tachycardia-characteristics.
    Podczeck A; Borggrefe M; Bartels K; Breithardt G
    Eur Heart J; 1989 Oct; 10(10):928-34. PubMed ID: 2513204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Oct; 31(10):1227-43. PubMed ID: 9337449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Flecainide and anti-arrhythmia therapy].
    Croce L; Romano S; Pozzoni L; Lomuscio A
    Minerva Med; 1988 Mar; 79(3):229-34. PubMed ID: 3129677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flecainide therapy in patients treated for supraventricular tachycardia with near normal left ventricular function.
    Hughes MM; Trohman RG; Simmons TW; Castle LW; Wilkoff BL; Morant VA; Maloney JD
    Am Heart J; 1992 Feb; 123(2):408-12. PubMed ID: 1736577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
    Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Bonnet P; Scala PJ; Demeyer JF
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():81-90. PubMed ID: 3938264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A shared pathway in atrioventricular nodal reentrant tachycardia and atrial flutter: implications for pathophysiology and therapy.
    Interian A; Cox MM; Jimenez RA; Duran A; Levin E; Garcia O; Cooper DK; Castellanos A; Myerburg RJ
    Am J Cardiol; 1993 Feb; 71(4):297-303. PubMed ID: 8427171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment.
    Uzun O; Babaoglu K; Sinha A; Massias S; Beattie B
    Cardiol Young; 2012 Aug; 22(4):372-80. PubMed ID: 22008551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Catheter ablation in supraventricular tachycardia].
    Pitschner HF; Neuzner J
    Z Kardiol; 1996; 85 Suppl 6():45-60. PubMed ID: 9064982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained intraatrial reentrant tachycardia: clinical, electrocardiographic and electrophysiologic characteristics and long-term follow-up.
    Haines DE; DiMarco JP
    J Am Coll Cardiol; 1990 May; 15(6):1345-54. PubMed ID: 2329238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opposite effects of propafenone and flecainide in a patient with reciprocating supraventricular tachycardia.
    Montenero AS; Natale A; di Bona G; Calvi V; Santarelli P; Manzoli U
    Cardiologia; 1990 Mar; 35(3):253-6. PubMed ID: 2123130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
    Kim SS; Lal R; Ruffy R
    Am J Cardiol; 1986 Jul; 58(1):80-5. PubMed ID: 3728336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia.
    Kuck KH; Kunze KP; Schlüter M; Duckeck W
    Am J Cardiol; 1988 Dec; 62(19):37L-44L. PubMed ID: 3144166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of a "bystander" concealed accessory pathway in the response to verapamil and flecainide treatment in a patient with nodal reentry tachycardia].
    Matteucci C; Busi G
    G Ital Cardiol; 1996 Apr; 26(4):419-25. PubMed ID: 8707026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia].
    Musto B; D'Onofrio A; Cavallaro C; Musto A; Della Gatta O; Marsico F
    G Ital Cardiol; 1987 May; 17(5):444-9. PubMed ID: 3115857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using the right drug: a treatment algorithm for regular supraventricular tachycardias.
    Lévy S; Ricard P
    Eur Heart J; 1997 May; 18 Suppl C():C27-32. PubMed ID: 9152672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Electrophysiological testing of multiple antiarrhythmic drugs in patients with paroxysmal supraventricular tachycardia after chronic oral administration].
    Nishino T
    Hokkaido Igaku Zasshi; 1989 Nov; 64(6):738-48. PubMed ID: 2606448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.